Literature DB >> 11701232

The transcription of the peroxisome proliferator-activated receptor alpha gene is regulated by protein kinase C.

N S Yaacob1, M N Norazmi, G G Gibson, G E Kass.   

Abstract

The transcriptional regulation of peroxisome proliferator-activated receptor alpha (PPARalpha) by a variety of peroxisome proliferators was investigated. The treatment of primary cultures of rat hepatocytes with Wy14,643 or clofibrate increased mRNA steady state levels of both PPARalpha and acyl coenzyme A oxidase (ACOX). In contrast, fenofibrate and ciprofibrate increased the expression of ACOX without affecting that of PPARalpha. Inhibition of protein kinase C (PKC) activity using bisindolylmaleimide or calphostin C abolished the increased PPARalpha expression by the peroxisome proliferators whereas the expression of the ACOX gene remained unaffected. Phorbol-12-myristate-13-acetate increased PPARalpha mRNA levels without altering ACOX mRNA levels. It can thus be concluded that a number of peroxisome proliferators activate a PKC-dependent signalling pathway in addition to the PPARalpha pathway. The PKC signal transduction pathway contributes to the regulation of PPARalpha expression but does not influence the transcriptional activity of PPARalpha.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11701232     DOI: 10.1016/s0378-4274(01)00433-7

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  6 in total

Review 1.  Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease.

Authors:  Jeff L Staudinger; Kristin Lichti
Journal:  Mol Pharm       Date:  2007-12-27       Impact factor: 4.939

2.  PPARα is regulated by miR-21 and miR-27b in human liver.

Authors:  Katsuhiko Kida; Miki Nakajima; Takuya Mohri; Yuki Oda; Shingo Takagi; Tatsuki Fukami; Tsuyoshi Yokoi
Journal:  Pharm Res       Date:  2011-05-12       Impact factor: 4.200

3.  Effects of lipid-lowering pharmaceutical clofibrate on lipid and lipoprotein metabolism of grass carp (Ctenopharyngodon idellal Val.) fed with the high non-protein energy diets.

Authors:  Xiaoze Guo; Xu-Fang Liang; Liu Fang; Xiaochen Yuan; Yi Zhou; Shan He; Dan Shen
Journal:  Fish Physiol Biochem       Date:  2014-09-12       Impact factor: 2.794

Review 4.  The Glitazars Paradox: Cardiotoxicity of the Metabolically Beneficial Dual PPARα and PPARγ Activation.

Authors:  Charikleia Kalliora; Konstantinos Drosatos
Journal:  J Cardiovasc Pharmacol       Date:  2020-11       Impact factor: 3.271

Review 5.  PPARs: Protectors or Opponents of Myocardial Function?

Authors:  Christine J Pol; Melissa Lieu; Konstantinos Drosatos
Journal:  PPAR Res       Date:  2015-12-02       Impact factor: 4.964

6.  Effects of naringin and valproate interaction on liver steatosis and dyslipidaemia parameters in male C57BL6 mice.

Authors:  David Jutrić; Domagoj Đikić; Almoš Boroš; Dyna Odeh; Sandra Domjanić Drozdek; Romana Gračan; Petar Dragičević; Irena Crnić; Irena Landeka Jurčević
Journal:  Arh Hig Rada Toksikol       Date:  2022-04-07       Impact factor: 2.078

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.